Restoring confidence in vaccines by explaining vaccine safety monitoring

Is a targeted approach needed?

Rachel E. Casiday, Anthony R. Cox

Research output: Contribution to journalArticle

Abstract

Public trust in childhood vaccines is crucial to achieving adequate immunisation coverage to ensure population-level immunity. However, in the UK, immunisation uptake has been adversely affected by vaccine safety scares, such as those surrounding whooping cough and measles, mumps and rubella (MMR). It is our belief that greater public awareness of safety surveillance schemes may play a key role in improving trust in vaccine safety. Many parents of vaccination-age children are unaware of the procedures in place for postmarketing surveillance of vaccines. Thus, we propose specific steps for generating such awareness, such as assisting parents to report suspected adverse reactions directly to the Medicines and Healthcare products Regulatory Agency (MHRA) via the Yellow Card scheme, providing information about adverse reaction reporting with vaccination information packs, and displaying posters and leaflets to convey the message that patient concerns and experiences are taken seriously by the MHRA and to generate further awareness about the scheme. In addition, healthcare staff should be encouraged to report suspected adverse reactions relating to vaccine products. Unresolved issues about the scientific usefulness of data reported by parents and the potential for these steps to increase parental concern and expectations require further investigation.

Original languageEnglish
Pages (from-to)1105-1109
Number of pages5
JournalDrug Safety
Volume29
Issue number12
DOIs
Publication statusPublished - 18 Dec 2006

Fingerprint

Vaccines
Safety
Monitoring
Immunization
Parents
Delivery of Health Care
Medicine
Vaccination
Posters
Mumps
Rubella
Whooping Cough
Measles
Immunity
Population

Cite this

Casiday, Rachel E. ; Cox, Anthony R. / Restoring confidence in vaccines by explaining vaccine safety monitoring : Is a targeted approach needed?. In: Drug Safety. 2006 ; Vol. 29, No. 12. pp. 1105-1109.
@article{6e4c98a6844049709148d9edda2b0f17,
title = "Restoring confidence in vaccines by explaining vaccine safety monitoring: Is a targeted approach needed?",
abstract = "Public trust in childhood vaccines is crucial to achieving adequate immunisation coverage to ensure population-level immunity. However, in the UK, immunisation uptake has been adversely affected by vaccine safety scares, such as those surrounding whooping cough and measles, mumps and rubella (MMR). It is our belief that greater public awareness of safety surveillance schemes may play a key role in improving trust in vaccine safety. Many parents of vaccination-age children are unaware of the procedures in place for postmarketing surveillance of vaccines. Thus, we propose specific steps for generating such awareness, such as assisting parents to report suspected adverse reactions directly to the Medicines and Healthcare products Regulatory Agency (MHRA) via the Yellow Card scheme, providing information about adverse reaction reporting with vaccination information packs, and displaying posters and leaflets to convey the message that patient concerns and experiences are taken seriously by the MHRA and to generate further awareness about the scheme. In addition, healthcare staff should be encouraged to report suspected adverse reactions relating to vaccine products. Unresolved issues about the scientific usefulness of data reported by parents and the potential for these steps to increase parental concern and expectations require further investigation.",
author = "Casiday, {Rachel E.} and Cox, {Anthony R.}",
year = "2006",
month = "12",
day = "18",
doi = "10.2165/00002018-200629120-00002",
language = "English",
volume = "29",
pages = "1105--1109",
journal = "Drug Safety",
issn = "0114-5916",
publisher = "Adis International Ltd",
number = "12",

}

Restoring confidence in vaccines by explaining vaccine safety monitoring : Is a targeted approach needed? / Casiday, Rachel E.; Cox, Anthony R.

In: Drug Safety, Vol. 29, No. 12, 18.12.2006, p. 1105-1109.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Restoring confidence in vaccines by explaining vaccine safety monitoring

T2 - Is a targeted approach needed?

AU - Casiday, Rachel E.

AU - Cox, Anthony R.

PY - 2006/12/18

Y1 - 2006/12/18

N2 - Public trust in childhood vaccines is crucial to achieving adequate immunisation coverage to ensure population-level immunity. However, in the UK, immunisation uptake has been adversely affected by vaccine safety scares, such as those surrounding whooping cough and measles, mumps and rubella (MMR). It is our belief that greater public awareness of safety surveillance schemes may play a key role in improving trust in vaccine safety. Many parents of vaccination-age children are unaware of the procedures in place for postmarketing surveillance of vaccines. Thus, we propose specific steps for generating such awareness, such as assisting parents to report suspected adverse reactions directly to the Medicines and Healthcare products Regulatory Agency (MHRA) via the Yellow Card scheme, providing information about adverse reaction reporting with vaccination information packs, and displaying posters and leaflets to convey the message that patient concerns and experiences are taken seriously by the MHRA and to generate further awareness about the scheme. In addition, healthcare staff should be encouraged to report suspected adverse reactions relating to vaccine products. Unresolved issues about the scientific usefulness of data reported by parents and the potential for these steps to increase parental concern and expectations require further investigation.

AB - Public trust in childhood vaccines is crucial to achieving adequate immunisation coverage to ensure population-level immunity. However, in the UK, immunisation uptake has been adversely affected by vaccine safety scares, such as those surrounding whooping cough and measles, mumps and rubella (MMR). It is our belief that greater public awareness of safety surveillance schemes may play a key role in improving trust in vaccine safety. Many parents of vaccination-age children are unaware of the procedures in place for postmarketing surveillance of vaccines. Thus, we propose specific steps for generating such awareness, such as assisting parents to report suspected adverse reactions directly to the Medicines and Healthcare products Regulatory Agency (MHRA) via the Yellow Card scheme, providing information about adverse reaction reporting with vaccination information packs, and displaying posters and leaflets to convey the message that patient concerns and experiences are taken seriously by the MHRA and to generate further awareness about the scheme. In addition, healthcare staff should be encouraged to report suspected adverse reactions relating to vaccine products. Unresolved issues about the scientific usefulness of data reported by parents and the potential for these steps to increase parental concern and expectations require further investigation.

UR - http://www.scopus.com/inward/record.url?scp=33845410482&partnerID=8YFLogxK

UR - https://link.springer.com/article/10.2165%2F00002018-200629120-00002

U2 - 10.2165/00002018-200629120-00002

DO - 10.2165/00002018-200629120-00002

M3 - Article

VL - 29

SP - 1105

EP - 1109

JO - Drug Safety

JF - Drug Safety

SN - 0114-5916

IS - 12

ER -